Patents by Inventor Min-Jung Lim

Min-Jung Lim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9289457
    Abstract: The present invention relates to a composition for preventing or treating liver diseases, which contains, as an active ingredient, any one or more of a homogeneous cell line derived from the cambium of Panax ginseng, including wild ginseng or ginseng, a lysate thereof, an extract thereof and a culture medium thereof. The homogeneous cell line according to the present invention, a lysate thereof, an extract thereof and a culture medium thereof have minimized side effects compared to existing agents for treating liver diseases, and thus are safe for the human body. Also, they can increase the levels of s-antibody (HBsAb) and e-antibody (HBeAb) against hepatitis virus and inhibit the proliferation of hepatitis virus, and thus they are useful for the prevention and treatment of liver diseases. In addition, they have the effect of lowering the levels of liver injury, and thus are useful as a functional food for improving liver function.
    Type: Grant
    Filed: April 16, 2013
    Date of Patent: March 22, 2016
    Assignees: UNHWA COPRORATION
    Inventors: Young Woo Jin, Eun Kyong Lee, Min Jung Lim
  • Patent number: 9095532
    Abstract: The present invention relates to an anti-aging or antioxidant composition which contains, as an active ingredient, a plant stem cell line derived from the cambium of Panax ginseng, including wild ginseng and ginseng, or an extract thereof, a lysate thereof and a culture thereof. The composition has minimized side effects compared to existing anti-aging agents and antioxidants, and thus is safe for the skin. Also, the composition of the present invention shows an antioxidant effect of inhibiting reactive oxygen species caused by exposure to UV radiation that is the major cause of skin aging, and it can effectively reduce or inhibit aging-related factors. Thus, the composition is useful for the prevention and inhibition of aging.
    Type: Grant
    Filed: April 16, 2013
    Date of Patent: August 4, 2015
    Assignees: Unhwa Corporation
    Inventors: Mi Ok Jang, Min Jung Lim, Il Seok Oh, Dae Hee Lee, Eun Kyong Lee, Young Woo Jin
  • Patent number: 8790927
    Abstract: The present invention relates to a composition for preventing or treating cancer, which contains, as an active ingredient, a Taxus cambium- or procambium-derived cell line; a lysate thereof; an extract thereof; or a culture medium thereof. The cell line, the lysate, the extract, and the culture medium has minimized side effects compared to the conventional therapeutic drugs, is safe to the human body, is involved directly in the growth of cancer to induce cancer cell death, and shows anticancer activity of inhibiting angiogenesis occurring in carcinogenesis. Accordingly, the cell line, the lysate, the extract and the culture medium is useful for the prevention, treatment and alleviation of cancer.
    Type: Grant
    Filed: January 31, 2013
    Date of Patent: July 29, 2014
    Assignee: Unhwa Corporation
    Inventors: Joong Hyun Park, Min Jung Lim, Il Seok Oh, Dae Hee Lee, Jung Chang Lee, Eun Kyong Lee, Young Woo Jin
  • Patent number: 8617621
    Abstract: The present invention relates to a composition for enhancing immunity, comprising one or more of the following: a homogenous cell line, and a lysate, an extract and a culture medium thereof as an active ingredient. The homogenous cell line, the lysate, the extract and the culture thereof according to the present invention, which are derived from a natural product, minimize adverse side effects of prior immune enhancing agents and safe for the human body. Further, they effectively increase the activity of NK cells responsible for innate immunity, as well as increase the proliferation rate of lymph node cells when the cells were re-exposed to an antigen in a specific immune reaction to enhance acquired immunity, and thus are useful as an immune enhancing agent.
    Type: Grant
    Filed: February 23, 2010
    Date of Patent: December 31, 2013
    Assignees: Unhwa Corporation
    Inventors: Min Jung Lim, Young Woo Jin, Eun Kyong Lee
  • Publication number: 20130302287
    Abstract: The present invention relates to an anti-aging or antioxidant composition which contains, as an active ingredient, a plant stem cell line derived from the cambium of Panax ginseng, including wild ginseng and ginseng, or an extract thereof, a lysate thereof and a culture thereof. The composition has minimized side effects compared to existing anti-aging agents and antioxidants, and thus is safe for the skin. Also, the composition of the present invention shows an antioxidant effect of inhibiting reactive oxygen species caused by exposure to UV radiation that is the major cause of skin aging, and it can effectively reduce or inhibit aging-related factors. Thus, the composition is useful for the prevention and inhibition of aging.
    Type: Application
    Filed: April 16, 2013
    Publication date: November 14, 2013
    Inventors: Mi Ok Jang, Min Jung Lim, Il Seok Oh, Dae Hee Lee, Eun Kyong Lee, Young Woo Jin
  • Publication number: 20120189660
    Abstract: The present invention relates to a composition for preventing or treating liver diseases, which contains, as an active ingredient, any one or more of a homogeneous cell line derived from the cambium of Panax ginseng, including wild ginseng or ginseng, a lysate thereof, an extract thereof and a culture medium thereof. The homogeneous cell line according to the present invention, a lysate thereof, an extract thereof and a culture medium thereof have minimized side effects compared to existing agents for treating liver diseases, and thus are safe for the human body. Also, they can increase the levels of s-antibody (HBsAb) and e-antibody (HBeAb) against hepatitis virus and inhibit the proliferation of hepatitis virus, and thus they are useful for the prevention and treatment of liver diseases. In addition, they have the effect of lowering the levels of liver injury, and thus are useful as a functional food for improving liver function.
    Type: Application
    Filed: August 14, 2009
    Publication date: July 26, 2012
    Inventors: Young Woo Jin, Eun Kyong Lee, Min Jung Lim
  • Publication number: 20120039918
    Abstract: The present invention relates to a composition for enhancing immunity, comprising one or more of the following: a homogenous cell line, and a lysate, an extract and a culture medium thereof as an active ingredient. The homogenous cell line, the lysate, the extract and the culture thereof according to the present invention, which are derived from a natural product, minimize adverse side effects of prior immune enhancing agents and safe for the human body. Further, they effectively increase the activity of NK cells responsible for innate immunity, as well as increase the proliferation rate of lymph node cells when the cells were re-exposed to an antigen in a specific immune reaction to enhance acquired immunity, and thus are useful as an immune enhancing agent.
    Type: Application
    Filed: February 23, 2010
    Publication date: February 16, 2012
    Applicant: Unhwa Corporation
    Inventors: Min Jung Lim, Young Woo Jin, Eun Kyong Lee
  • Publication number: 20110097310
    Abstract: The present invention relates to an anti-aging or antioxidant composition which contains, as an active ingredient, a plant stem cell line derived from the cambium of Panax ginseng, including wild ginseng and ginseng, or an extract thereof, a lysate thereof and a culture thereof. The composition has minimized side effects compared to existing anti-aging agents and antioxidants, and thus is safe for the skin. Also, the composition of the present invention shows an antioxidant effect of inhibiting reactive oxygen species caused by exposure to UV radiation that is the major cause of skin aging, and it can effectively reduce or inhibit aging-related factors. Thus, the composition is useful for the prevention and inhibition of aging.
    Type: Application
    Filed: June 12, 2009
    Publication date: April 28, 2011
    Applicant: UNHWA CORPORATION
    Inventors: Mi Ok Jang, Min Jung Lim, Il Seok Oh, Dae Hee Lee, Eun Kyong Lee, Young Woo Jin
  • Publication number: 20100272692
    Abstract: The present invention relates to a composition for preventing or treating cancer, which contains, as an active ingredient, a Taxus cambium- or procambium-derived cell line; a lysate thereof; an extract thereof; or a culture medium thereof. The cell line, the lysate, the extract, and the culture medium has minimized side effects compared to the conventional therapeutic drugs, is safe to the human body, is involved directly in the growth of cancer to induce cancer cell death, and shows anticancer activity of inhibiting angiogenesis occurring in carcinogenesis. Accordingly, the cell line, the lysate, the extract and the culture medium is useful for the prevention, treatment and alleviation of cancer.
    Type: Application
    Filed: October 10, 2008
    Publication date: October 28, 2010
    Applicant: UNHWA CORPORATION
    Inventors: Joong Hyun Park, Min Jung Lim, Il Seok Oh, Dae Hee Lee, Jung Chang Lee, Eun Kyong Lee, Young Woo Jin
  • Patent number: 5834437
    Abstract: The object of the present invention is to provide asiatic acid derivatives, its pharmaceutically acceptable salts or esters.Asiatic acid, its trisaccharide asiaticoside and mddecassic acid, extracted from Centella asiatica have been used for a long time in the management of skin scars and chronic ulcers. In this invention, asiatic acid derivatives synthesized from asiatic acid show excellent wound-healing properties.
    Type: Grant
    Filed: December 1, 1995
    Date of Patent: November 10, 1998
    Assignee: Dong Kook Pharmaceutical Co., Ltd.
    Inventors: Sang-Sup Jew, Hee-Doo Kim, Young-Hoon Jung, Eun-Hee Park, Sung-Ki Seo, Tae-Gyu Nam, Duc-Ky Hahn, Jae-Ho Park, Pil-Jong Sim, Min-Jung Lim, Kyung-Haw Lim